Shanghai Fosun Pharmaceutical (Group) Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 21,274.61 million compared to CNY 16,877.54 million a year ago. Net income was CNY 1,553.5 million compared to CNY 2,482.37 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.67 CNY | -0.17% | +3.45% | -5.43% |
04-30 | Fosun Pharma's Q1 Profit Slumps 38% | MT |
04-29 | Shanghai Fosun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.43% | 7.83B | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Shanghai Fosun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022